- Home
- QUCY vs FBIO Comparison
QUCY vs FBIO Comparison
Compare QUCY & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$1.99
Company Overview
Basic Information| Metric | QUCY | FBIO |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.6M | 80.4M |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | QUCY | FBIO |
|---|---|---|
| Price | $0.72 | $1.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 425.9K | 202.4K |
| Earning Date | 08-14-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 87.68 | ★ 97.40 |
| EPS | N/A | ★ 2.86 |
| Revenue | $537,080.00 | ★ $63,262,000.00 |
| Revenue This Year | $281.69 | $24.55 |
| Revenue Next Year | $123.17 | $43.73 |
| P/E Ratio | ★ N/A | $0.65 |
| Revenue Growth | N/A | ★ 9.69 |
| 52 Week Low | $0.30 | $1.79 |
| 52 Week High | $4.93 | $4.53 |
Technical Indicators
Market Signals| Indicator | QUCY | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 29.49 | 47.24 |
| Support Level | $0.42 | $1.83 |
| Resistance Level | $1.53 | $2.07 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 12.45 | 66.31 |
Price Performance
Historical Comparison QUCY
FBIO
About QUCY Mainz Biomed N.V. Ordinary Shares
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.